Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quality Assurance01:19

Quality Assurance

3.7K
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monte Carlo assessment of a treatment planning system for intraoperative radiotherapy in the presence of tissue heterogeneities.

Medical physics·2026
Same author

Maternal Identity and Role Balance in Pregnancy: Construction and Validation of the Maternal Role Integration Questionnaire (MRIQ-P).

Behavioral sciences (Basel, Switzerland)·2026
Same author

Guide for quality control and safety of external radiotherapy treatment planning systems and treatment plans.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells <i>ex vivo</i> and <i>in vivo</i>, especially if combined with daratumumab.

Oncoimmunology·2025
Same author

One Year After Mild COVID-19: Emotional Distress but Preserved Cognition in Healthcare Workers.

Journal of clinical medicine·2025
Same author

Decoupling working memory impairment from grey matter volume changes in female patients with fibromyalgia: Moderating effect of depression.

NeuroImage·2025

Related Experiment Video

Updated: Mar 12, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K

On the new metrics for IMRT QA verification.

Alejandro Garcia-Romero1, Araceli Hernandez-Vitoria1, Esther Millan-Cebrian1

  • 1Servicio de Fisica y Proteccion Radiologica, Hospital Clinico Universitario "Lozano Blesa" de Zaragoza, Avenida San Juan Bosco 15, Zaragoza E-50009, Spain.

Medical Physics
|November 4, 2016
PubMed
Summary

New metrics for intensity-modulated radiation therapy (IMRT) verification improve plan acceptance and rejection criteria. These advanced methods, including dose difference global functions and 3D gamma analysis, offer more reliable clinical assessments than conventional approaches.

More Related Videos

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
06:33

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement

Published on: July 29, 2013

11.7K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Related Experiment Videos

Last Updated: Mar 12, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K
Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
06:33

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement

Published on: July 29, 2013

11.7K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiotherapy Verification

Background:

  • Intensity-modulated radiation therapy (IMRT) verification is crucial for patient safety and treatment efficacy.
  • Conventional metrics for IMRT verification present discrepancies and may not accurately reflect clinical relevance.
  • There is a need for improved metrics that provide more reliable acceptance and rejection criteria.

Purpose of the Study:

  • To identify new metrics for more reliable acceptance/rejection criteria in IMRT verification.
  • To address discrepancies among conventional IMRT verification metrics.
  • To evaluate new metrics based on dose-volume histogram data, dose differences, and modified radiobiological models (tumor control probability [TCP] and normal tissue complication probability [NTCP]).

Main Methods:

  • Analysis of 58 treatment plans using both conventional and newly proposed metrics.
  • Development of new metrics based on dose-volume histogram processing, including continuous functions, dose differences, and modified TCP/NTCP models.
  • Calculation of 3D gamma functions and a radiobiological robustness index for plan classification.

Main Results:

  • A dose difference global function, optimized via ROC analysis, effectively condenses dose difference metrics.
  • Modified radiobiological models (TCP/NTCP) show better correlation with dose changes than conventional models.
  • The robustness index predicts plan rejection probability, and the 3D gamma metric correlates well with dose difference metrics, performing effectively in acceptance/rejection processes.

Conclusions:

  • The dose difference global function and 3D gamma metric are effective classifiers for dose differences.
  • Modified TCP and NTCP functions improve the correlation between radiobiological models and dose-based metrics.
  • New metrics, particularly the robustness index and 3D gamma, offer clinically relevant assessments and should replace conventional verification methods.